Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy

Qintao Gea Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China;b Institute of Urology, Anhui Medical University, Hefei, P.R. China;c Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, P.R. ChinaView further author information

Jiawei Lia Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China;b Institute of Urology, Anhui Medical University, Hefei, P.R. China;c Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, P.R. ChinaView further author information

Feixiang Yanga Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China;b Institute of Urology, Anhui Medical University, Hefei, P.R. China;c Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, P.R. ChinaView further author information

Xuefeng Tiand Anhui Medical University, Hefei, P.R. ChinaView further author information

Meng Zhanga Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China;b Institute of Urology, Anhui Medical University, Hefei, P.R. China;c Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, P.R. ChinaView further author information

Zongyao Haoa Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China;b Institute of Urology, Anhui Medical University, Hefei, P.R. China;c Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, P.R. ChinaView further author information

Chaozhao Lianga Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China;b Institute of Urology, Anhui Medical University, Hefei, P.R. China;c Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, P.R. ChinaCorrespondence[email protected]
View further author information

Jialin Menga Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China;b Institute of Urology, Anhui Medical University, Hefei, P.R. China;c Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, P.R. ChinaCorrespondence[email protected]
View further author information

show all

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date